iifl-logo-icon 1

Parabolic Drugs Ltd Cash Flow Statement

5.5
(-4.35%)
Jan 25, 2021|01:00:21 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Parabolic Drugs Ltd FINANCIALS

Y/e 31 Mar( In .Cr)Mar-2018Mar-2017Mar-2016Mar-2015

Profit before tax

-55.24

-105.01

-480.75

-248.99

Depreciation

-34.53

-53.48

-67.05

-72.96

Tax paid

-1.75

-3.05

-4.43

-130.32

Working capital

-15.37

-43.6

-399

-76.64

Other operating items

Operating

-106.9

-205.15

-951.24

-528.93

Capital expenditure

-1.6

-0.03

-3.24

87.64

Free cash flow

-108.51

-205.18

-954.48

-441.29

Equity raised

-1,702.43

-1,486.3

-515.92

242.39

Investing

0

0

0

0.18

Financing

76.2

76.28

79.24

180.31

Dividends paid

0

0

0

0

Net in cash

-1,734.74

-1,615.2

-1,391.15

-18.4

Parabolic Drugs Ltd : related Articles

No Record Found

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2024, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp